Here’s two new ETFs for Canadian investors

Article Excerpt

This month we take a look at a new healthcare ETF from TD Asset Management, plus a very unique ETF from Horizons that focus on companies looking to develop psychedelic drugs for the treatment of mental illness. TD Asset Management recently launched the TD Global Healthcare Leaders Index ETF $15.57 (Toronto symbol TDOC). This new fund invests in large and medium-sized healthcare companies located anywhere in the world. The ETF tracks the Solactive Global Healthcare Leaders Index. Individual holdings are capped at 2% on the rebalancing dates. Most of the assets are currently allocated to U.S. stocks (66%), followed by Europe 23%) and Japan (7%). Top holdings include CVS Health, United Health, Novo Nordisk, AstraZeneca, Pfizer, and AbbVie. The fund launched on April 14, 2021, and charges a management fee of 0.35%. The asset base is still small, with assets worth only $6.14 million. This ETF is a buy if you want to own the top global healthcare stocks. The Horizons Psychedelic Stock Index ETF…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.